Related Experiment Videos
[Regression of coronary arteriosclerosis with hypolipidemic treatment, myth or reality?]
C Lahoz1, A Monereo, J M Mostaza
1Unidad de Arterioesclerosis, Instituto de Salud Carlos III, Fundación Jiménez Díaz, Madrid.
Abstract:
Coronary atherosclerosis regression with hypolipemiant treatment is a well known fact in the animal model since years ago. In humans, during these last years, several clinical trials have been performed to ellucidate the truth to this fact. All of these clinical trials have in common the evolutive study of the coronary lesions with angiographies, in patients following treatment with diet, surgery or drugs, to reduce plasmatic cholesterol. Clinical, analytical and angiographic results of said studies are reviewed. We conclude that the bigger the lowering in plasmatic cholesterol levels, smaller is the progression of these coronary lesions and more probable is finding patients with partial regression of the lesions.
Insights
Lowering cholesterol through diet, surgery, or medication can reduce the progression of coronary atherosclerosis. Significant cholesterol reduction increases the likelihood of lesion regression in patients.
Area of Science:
- Cardiovascular Medicine
- Atherosclerosis Research
- Lipid Metabolism
Context:
- Coronary atherosclerosis regression is established in animal models.
- Human clinical trials investigating lipid-lowering treatments are ongoing.
- Angiography tracks coronary lesion changes in patients undergoing cholesterol reduction therapies.
Purpose:
- To review clinical, analytical, and angiographic data from human trials on coronary atherosclerosis regression.
- To assess the impact of cholesterol-lowering interventions on coronary lesion progression and regression.
Summary:
- Clinical trials involving diet, surgery, or drugs to reduce plasma cholesterol were reviewed.
- Angiographic studies monitored coronary lesion evolution in patients.
- A direct correlation was observed between the degree of plasma cholesterol reduction and reduced lesion progression.
Impact:
- Significant reduction in plasma cholesterol levels is associated with slower coronary lesion progression.
- Greater cholesterol lowering enhances the probability of partial regression of coronary atherosclerotic lesions.
- Findings support the efficacy of hypolipidemic treatments in managing coronary atherosclerosis.